OXITRIPTAN for Dopa-responsive dystonia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where OXITRIPTAN was used for Dopa-responsive dystonia.
Most Reported Side Effects for OXITRIPTAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Serotonin syndrome | 22 | 22.0% | 0 | 18 |
| Anxiety | 21 | 21.0% | 0 | 1 |
| Insomnia | 19 | 19.0% | 0 | 1 |
| Atrial fibrillation | 18 | 18.0% | 0 | 1 |
| Bradycardia | 18 | 18.0% | 0 | 1 |
| Gastric ph increased | 18 | 18.0% | 0 | 1 |
| Somnolence | 18 | 18.0% | 0 | 12 |
| Drug interaction | 10 | 10.0% | 0 | 9 |
| Myoclonus | 10 | 10.0% | 0 | 5 |
| Off label use | 8 | 8.0% | 1 | 3 |
| Diarrhoea | 7 | 7.0% | 0 | 0 |
| Migraine | 7 | 7.0% | 0 | 1 |
| Product use in unapproved indication | 7 | 7.0% | 0 | 3 |
| Headache | 6 | 6.0% | 0 | 1 |
| Condition aggravated | 5 | 5.0% | 0 | 0 |
Other Indications for OXITRIPTAN
Product used for unknown indication (38)
Tonic convulsion (10)
Migraine (6)
Post-traumatic epilepsy (5)